Expert in leading cross-species studies focusing on animal models of rare disorders, successfully navigating collaborations and project management with stakeholders from academic, non-profit and industry sectors. Garnered funding through grant writing, cultivated effective teams, and mentored budding talents. Proven success in managing project timelines, budgets, addressing challenges, and presenting research findings at various scientific forums, all while championing the cause of preclinical gene therapy studies.Thesis work focused on exploring the validity and practical implementation of innovative rat models for various genomic imprinting disorders, such as Prader-Willi, Schaaf-Yang, Angelman, and Dup15q syndromes, alongside other rare neurodevelopmental conditions.Proficient in handling complex and intricate tasks, including overseeing expansive colony management and conducting comprehensive behavioral phenotyping of genetically modified rodent CNS models. Equipped with the detailed analytical skills to execute projects from initial design to employing diverse techniques across multi-platforms with final data analysis and presentation.